Ethics & compliance

Dedicated to responsible corporate action at every level

At Exelixis, we strive for the highest standards of business conduct and ethics. The Exelixis Corporate Code of Conduct (Code) reflects the business practices and principles of behavior that support this commitment. Each Exelixis officer, employee, director, agent and contractor is expected to maintain the standards established in our Code of Conduct and adhere to the policies created in support of the Code.

At Exelixis, we encourage our employees and stakeholders to ask questions, and we provide multiple channels via which to do so or raise compliance concerns. Anti-retaliation and confidentiality policies are in place to protect individuals who raise concerns of misconduct in good faith. Beyond their immediate supervisors or other managers, staff raise questions or concerns with members of the Ethics Committee. Exelixis’ Ethics Helpline also enables staff or others to request guidance or report a concern anonymously.

California compliance declaration

Exelixis has established and is committed to maintaining a comprehensive and effective compliance program in accordance with California SB 1765 (California Business & Professions Code 119400, 119402) and the Office of Inspector General, U.S. Department of Health and Human Services, “Compliance Program Guidance for Pharmaceutical Manufacturers” (OIG Guidance).

Our Compliance Program reflects our unwavering commitment to the highest standards of corporate conduct and integrity.

Click here to view our Comprehensive Compliance Program.

Vermont pharmaceutical marketer price disclosure

Vermont law 18 V.S.A. § 4633 requires pharmaceutical marketers to disclose to Vermont doctors and other prescribers the prices of the drugs they market as well as the prices of other drugs in the same therapeutic class.

This page allows those doctors and other prescribers’ access to this information for applicable products that are manufactured and marketed by Exelixis.

Please choose either “Long form” or “Short form” below.

Being part of Exelixis at this exciting time is something very few people in this industry ever get the opportunity to observe yet alone experience. Regardless of what you do at Exelixis, you are witnessing and supporting transformative science that provides hope for cancer patients. We on the Government Affairs team are proud to represent Exelixis to educate lawmakers about our commitment to research and development and to align on key issues, so we can work alongside one another to move the needle for patients.

Erin Hermance

Executive Director, Government Affairs